2026-08-07T10:53:22-05:00 2025-09-30 010494526 Baker Newman & Noyes 280 Fore Street Suite 500 Portland ME 04101 990 2024-10-01 043358048 Lamoille Health Partners Inc LAMO 8028518607 609 Washington Highway Morrisville VT 05661 Randy Gibson CFO 8028518607 2026-08-04 1 0 Connor Smart P02285543 2078792100 2026-08-04 2024 2025-03-06 01:10:19Z Lance Broy MD 609 Washington Highway Morrisville VT 05661 27379463 0 X http://www.LamoilleHealthPartners.org X 1998 VT To provide quality integrated health care services and to promote wellness. 11 11 213 12 353077 0 5151347 4395688 19551195 21119116 8719 688325 0 0 24711261 26203129 3068 450 0 0 17053570 15593613 0 0 0 9286462 9305529 26343100 24899592 -1631839 1303537 11121535 9614454 9850230 7039612 1271305 2574842 To provide quality integrated health care services and promote wellness for residents of the Lamoille Valley Region. 0 0 17292382 450 20766039 The Organization provides ambulatory medical services in the Lamoille Valley including behavioral health and wellness services, substance use disorder treatment, psychiatry and telemedicine services, dentistry, and primary care physician services. 17292382 1 1 0 1 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 29 0 1 213 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 11 11 0 1 1 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 1 0 X Randy Gibson CFO 8028518607 609 Washington Highway Morrisville VT 05661 Shelly Citron Director (end 2/2025) 1.00 X 0 0 0 Aaron French Director (start 6/2025) 1.00 X 0 0 0 Scott Johnson Director (start 4/2025) 1.00 X 0 0 0 Mary Paul Loomis Director 1.00 X 0 0 0 Erica Scott Director (start 10/2024) 1.00 X 0 0 0 Jennifer Stratton Director (start 6/2025) 1.00 X 0 0 0 Dave Yacovone Director 1.00 X 0 0 0 Peter Anderson Vice Chair/Chair (start 12/24) 1.00 X X 0 0 0 Richard Westman Director/Vice Chair (start 12/24) 1.00 X X 0 0 0 Josh Smith Treasurer 1.00 X X 0 0 0 Alison Calderara Secretary (end 8/2025) 1.00 X X 0 0 0 Robert Bauman Dir. (start 3/25); Sec. (start 8/25) 1.00 X X 0 0 0 Susan Bartlett Chair/Interim CEO (start 12/2024) 24.00 X X 0 0 0 Stuart G May President/CEO (end 10/2024) 40.00 X 221185 0 9445 Evalie Crosby Interim CFO (end 12/2024) 40.00 X 8517 0 0 Lance Broy MD Chief Medical Officer 32.00 X 295805 0 12243 Randy Gibson CFO (start 9/2025) 40.00 X 0 0 0 Gail Messier Interim CFO (1/2025 thru 8/2025) 40.00 X 0 0 0 Linda Zamvil MD Physician 32.00 X 332017 0 23270 Steven Soriano DO Physician 40.00 X 240328 0 20380 Robert Quinn MD Physician 28.00 X 228433 0 23313 Katherine Marvin MD Physician 40.00 X 229472 0 21464 Melissa Volansky MD Physician 40.00 X 276951 0 21902 1832708 0 132017 24 0 1 0 BerryDunn 2211 Congress Street Portland ME 04102 Management and consulting 166026 1 4331800 63888 4395688 Patient service revenue 621110 14279931 14279931 Pharmacy services 623000 4452457 4099380 353077 340B contract revenue 621110 1219803 1219803 Pharmacy network 621110 599579 599579 Other program services 621110 567346 567346 21119116 3247 3247 1861412 1176334 685078 685078 685078 26203129 20766039 353077 688325 X 450 450 547195 308049 239146 12170821 8455948 3714873 404658 276822 127836 1553992 1029559 524433 916947 619155 297792 96808 96808 82400 82400 2328970 1236615 1092355 20230 1308 18922 477828 184146 293682 337234 12686 324548 598224 459295 138929 48445 46609 1836 71061 62148 8913 274291 9794 264497 412041 204573 207468 180065 21657 158408 340B drugs/med supplies 3848763 3848763 Provision for bad debts 382313 382313 Lab supplies 129511 129511 Recruitment 17345 2981 14364 24899592 17292382 7607210 0 66319 0 107234 0 114165 152756 1476006 1823690 298879 350342 185479 88810 10560831 4279575 7590908 6281256 210770 249443 706037 239359 365738 428798 11121535 9614454 3510651 2516137 367031 388513 5246268 3887195 726280 247767 9850230 7039612 X 1271305 2324029 250813 1271305 2574842 11121535 9614454 1303537 0 X X 0 1 X 1 1 1 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 0 0 1 417 0 0 0 417 0 Part II-B, Line 1: Lamoille Health Partners is a member of the Bi-State Primary Care Association, a health care industry group. It is possible that a portion of the dues paid to this Association was available for lobbying expenditures on behalf of Lamoille Health Partners and the other Association members in furtherance of their exempt purposes. At the time of filing this Form 990, the Association was unable to provide Lamoille Health Partners with an estimate of the portion of dues paid during this tax year that was available for lobbying. However, in past years, of the total dues paid, approximately 1.5% was determined to be used on lobbying expenditures. Accordingly, Lamoille Health Partners estimates that of the $27,821 in total dues paid during this year, approximately $417 may have been available for use by the Association on lobbying purposes. For transparency purposes, such has been reported on this Form 990, Schedule C, Part II-B, Line 1f. 591176 591176 5842129 1382617 4459512 1029389 878364 151025 2767352 2014471 752881 330785 4123 326662 6281256 Operating lease liabilities 247767 247767 X 25860516 39700 39700 25820816 382313 382313 26203129 24556979 39700 39700 24517279 382313 382313 24899592 Part X, Line 2: The Organization has been organized without capital stock and operates exclusively for charitable and/or educational purposes. The Organization complies with the provisions of Section 501(c)(3) of the Internal Revenue Code (IRC) to operate as a not-for-profit organization and is exempt from income taxes. As a tax-exempt public charity as described in Section 501(c)(3) of the IRC, only unrelated business income, as described by Section 512(a)(1) of the IRC, is subject to federal income tax. The Organization considers its activities to determine any unrelated business income filing and tax payment requirements as appropriate with its annual tax return submissions. Tax-exempt organizations could be required to record an obligation for income taxes as the result of a tax position they have historically taken on various tax exposure items including unrelated business income or tax status. Under guidance issued by the FASB, assets and liabilities are established for uncertain tax positions taken or positions expected to be taken in income tax returns when such positions are judged to not meet the "more-likely-than-not" threshold, based upon the technical merits of the position. The Organization has evaluated the position taken on its filed tax returns. The Organization has concluded no uncertain income tax positions exist at September 30, 2025. Part XI, Line 2d - Other Adjustments: Internal pharmacy rent adjustments 39,700. Part XI, Line 4b - Other Adjustments: Provision for bad debts 382,313. Part XII, Line 2d - Other Adjustments: Internal pharmacy rent adjustments 39,700. Part XII, Line 4b - Other Adjustments: Provision for bad debts 382,313. X X X 0 0 0 0 0 0 0 1 0 Linda Zamvil MD Physician 325359 0 0 0 6658 0 13143 0 10127 0 355287 0 0 0 Lance Broy MD Chief Medical Officer 283184 0 12000 0 621 0 2182 0 10061 0 308048 0 0 0 Melissa Volansky MD Physician 275790 0 0 0 1161 0 11071 0 10831 0 298853 0 0 0 Steven Soriano DO Physician 240132 0 0 0 196 0 9641 0 10739 0 260708 0 0 0 Robert Quinn MD Physician 228019 0 0 0 414 0 9288 0 14025 0 251746 0 0 0 Katherine Marvin MD Physician 229239 0 0 0 233 0 9264 0 12200 0 250936 0 0 0 Stuart G May President/CEO (end 10/2024) 219744 0 0 0 1441 0 8806 0 639 0 230630 0 0 0 Part I, Line 7 From time-to-time the Organization may provide bonuses, performance awards, or other non-fixed payments based on the accomplishments of defined metrics and goals. Non-fixed payments are subject to the Organization's standard compensation review and approval procedures. Form 990, Part VI, Section A, line 3 During the period covered by this Form 990, Lamoille Health Partners engaged two independent third-party professional services firms to provide interim Chief Financial Officer (CFO) services to the Organization: BerryDunn and Your Part Time Controller. Engagement with BerryDunn: As per the Interim CFO Agreement, BerryDunn provided the following services: interim CFO support and related services; budgeting and financial reporting; forecasting and projections; support for the CEO and other key employees and officers; and to assist in the development and recruitment of a permanent CFO role and BerryDunn's eventual replacement. The agreement with BerryDunn was signed effective January 2024. In March 2024, through the agreement with BerryDunn, Evalie Crosby was placed as the Interim CFO, in which role Ms. Crosby served through this tax year, and up until and into December 2024. In this capacity, Evalie Crosby fulfilled the same general responsibilities assigned to BerryDunn under the original Interim CFO Agreement. For December 2024 only, Ms. Crosby was considered an employee of Lamoille Health Partners. Accordingly, the compensation and benefits paid to Ms. Crosby as an employee and officer of Lamoille Health Partners are disclosed on this Form 990, Part VII. After December 2024, following new Board and officer assignments, Ms. Crosby ended her role as Interim CFO, and remained retained as a Finance Consultant for the Board on an as-needed basis only. Accordlying, as of the end of December 2024, Ms. Crosby was no longer an Officer of the Organization. While Ms. Crosby may have also received compensation from BerryDunn as an employee and/or contractor of or with BerryDunn, Lamoille Health Partners did not directly pay Ms. Crosby for her services, outside of the one-month period in December 2024 when she was deemed an employee. The total amount paid separately to BerryDunn during calendar year 2024, for all Interim CFO and other financial services, was $166,026. Engagement with Your Part Time Controller: The agreement with Your Part Time Controller ("YPTC") was signed effective December 2024. At such time, YPTC assumed many of the same responsibilities and powers previously held by BerryDunn, including such duties as: budgeting and financial reporting; forecasting and projections; support for the CEO and other key employees and officers; and to assist in the development and recruitment of a permanent CFO role. This arrangement with YPTC was held from December 2024 through August 2025. During that time, Gail Messier served as YPTC's representative and therefore as Lamoille Health Partners' Interim CFO. Accordingly, Ms. Messier has been deemed an Officer of the Board during part of this fiscal year. While Ms. Messier may have received compensation from YPTC as an employee and/or contractor with YPTC, Lamoille Health Partners did not directly pay Ms. Messier for her services. The total amount paid to YPTC during calendar year 2024, for all Interim CFO and other financial services, was $5,533. Lastly, as of the end of this year ending September 2025 and following the end of its engagement with YPTC, Randy Gibson has served as Lamoille Health Partners' full-time CFO. Form 990, Part VI, Section A, line 4 The Organization's bylaws were revised in September 2025 in the following significant ways: 1. The bylaws were revised to state that no more than 49 percent of Board members may be financially interested persons. 2. The bylaws were revised to explicitly state that the Finance Committee shall review the annual IRS Form 990 return and the annual financial audit, and the Finance Committee will meet periodically with the auditors. Form 990, Part VI, Section B, line 11b The Organization's Form 990 is prepared with the assistance of an independent public accounting firm. The draft is then thoroughly reviewed by the Finance Committee and other key financial staff. Once any changes are made, the Organization makes the Form 990 available for all Board Members to review via secure web portal, email, or in hard copy prior to filing with the IRS. Form 990, Part VI, Section B, line 12c Each Board member has a fiduciary duty to Lamoille Health Partners, Inc. (the, "corporation") and must give it his/her loyalty. The Board of Directors shall establish, adopt, and periodically update a written corporate policy that establishes procedures for discussing and addressing conflicts of interest or the appearance of conflicts of interest by Board members, officers, employees, consultants, and/or agents who provide services or furnish goods to the corporation, and for maintaining confidentiality. A director or officer shall disclose a conflict of interest: (a) prior to voting on or otherwise discharging his duties with respect to any matter involving the conflict which comes before the board or any committee; (b) prior to entering into any contract or transaction involving the conflict; (c) as soon as possible after the director or officer learns of the conflict; and (d) on the annual conflict of interest disclosure form. The Secretary of the corporation shall distribute annually to all directors and officers, a form soliciting the disclosure of conflicts of interest, including specific information concerning the terms of any contract or transaction with the corporation and whether the process for approval. Approval of Contracts and Transactions Involving Potential Conflicts of Interest: A director or officer who has or learns about a potential conflict of interest should disclose promptly to the Secretary of the corporation the material facts surrounding any actual or potential conflict of interest, including specific information concerning the terms of any contract or transaction with the corporation. All efforts should be made to disclose any such contract or transaction, and have it approved by the Board before the arrangement is entered into. Following receipt of information concerning a contract or transaction involving a potential conflict of interest, the Board shall consider the material facts concerning the proposed contract or transaction including the process by which the decision was made to recommend entering into the arrangement on the terms proposed. The Board shall approve only those contracts or transactions in which the terms are fair and reasonable to the corporation and the arrangements are consistent with the best interests of the corporation. Form 990, Part VI, Section B, line 15 The CEO compensation is determined and executed by the Board of Directors taking into consideration individual and organizational performance, experience, and comparable market rates for the position. All other officer and key employee compensation is determined by the CEO focusing on individual performance, experience, and utilizing outside compensation data. Form 990, Part VI, Section C, line 19 The Organization makes its governing documents, conflict of interest policy, audited financial statements, and Forms 1023 and 990 available to the public upon request at its central offices. Form 990, Part IX, Column D: The Organization did not incur any fundraising expenses during the current fiscal year. All grants are received primarily from state and federal sources on an on-going basis. Form 990, Part XI, Line 2c The audit process has not changed from the prior year. Form 990, Part VI, Line 16b: While no policy or procedure that is written exists, in every instance where Lamoille Health Partners (LHP) has entered into a joint venture, LHP has secured legal advice to understand the implications of entering into an LLC agreement and its impact on the Organization's tax exempt status. This is the normal procedure followed to safeguard the Organization's tax exempt status for all LLC agreements. Previously, LHP's Schedule R listed several LLC entities as related organizations which constituted the Organization's joint ventures. The Organization has disposed of its interest in all joint ventures it previously participated in with taxable entities in previous tax years.